Unique Device Identification for Postmarket Surveillance and Enforcement; Public Workshop

Health and Human Services Department; Food and Drug Administration · 2011

Read Unique Device Identification for Postmarket Surveillance and Enforcement; Public Workshop by Health and Human Services Department; Food and Drug Administration (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2011-18369.txt.

Description

Notice published in the Federal Register on 2011-07-21 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo). [Pages 43691-43693] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2011-18369] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2011-N-0495] Unique Device Identification for Postmarket Surveillance and Enforcement; Public Workshop AGENCY: Food and Drug Administration, HHS. ACTION:.

Catalog record

CREATORHealth and Human Services Department; Food and Drug Administration
YEAR2011
COLLECTIONLAW
FORMATTXT
FILE SIZE12 KB
VERSION1.0
LICENSEPublic Domain
RIGHTSPUBLIC DOMAIN
SOURCEFederal Register

Source: https://www.federalregister.gov/documents/2011/07/21/2011-18369/unique-device-identification-for-postmarket-surveillance-and-enforcement-public-workshop

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Unique Device Identification for Postmarket Surveillance and Enforcement; Public Workshop Citation: us:fr:2011-18369 Creator: Health and Human Services Department; Food and Drug Administration Year: 2011 Source-URL: https://www.federalregister.gov/documents/2011/07/21/2011-18369/unique-device-identification-for-postmarket-surveillance-and-enforcement-public-workshop Context: Notice published in the Federal Register on 2011-07-21 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo). [Pages 43691-43693] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2011-18369] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2011-N-0495] Unique Device Identification for Postmarket Surveillance and Enforcement; Public Workshop AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public workshop; request for comments. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is announcing a public workshop on the adoption, implementation, and use of unique device identifiers (UDIs) in various health-related electronic data systems. The purpose of this workshop is to engage multiple stakeholders to obtain information and comments on issues confronting the effective and efficient incorporation of UDIs into appropriate data sets, to identify barriers and incentives to their adoption and use, and to understand the best solutions and practices to resolve open issues. Dates and Times: The public workshop will be held on September 12, 2011, from 1 to 5 p.m. and on September 13, 2011, from 9 a.m. to 5 p.m. Submit electronic and written comments by October 13, 2011. Location: The public workshop will be held at the Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, Bethesda, MD 20852; 301-822-9200. Contact Person: Jay Crowley, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20903, 301-980-1936, e-mail: [email protected] Registration: Registration is free and will be on a first-come, first-served basis. To register for the public workshop--whether attending in person or for the Web cast--please visit http://www.fda.gov/UDI (or go the FDA Medical Devices News & Events--Workshops & Conferences calendar and select this public workshop from the posted events list). Please provide complete contact information for each attendee, including name, title, affiliation, address, e-mail, and telephone number. For those without Internet access, please contact Jay Crowley (see Contact Person) to register. Registration requests should be received by 5 p.m. on September 5, 2011. Early registration is recommended because seating is limited and, therefore, FDA may limit the number of participants from each organization. If time and space permit, onsite registration on the [[Page 43692]] day of the public workshop will be provided beginning at 11 a.m. Hotel reservations can be made by calling the hotel and requesting the group rate for the ``FDA UDI Public Workshop'' room block. If you need special accommodations due to a disability, please contact Jay Crowley ([email protected]) at least 7 days in advance. The meeting will also be Web cast. Persons interested in participating by Web cast must register online by 5 p.m. on September 5, 2011. Web cast participants will be sent connection requirements. More information on the Web cast can be found on our Web site at http://www.fda.gov/UDI. By August 12, 2011, and then as available, FDA will post the workshop agenda and discussion topics, registration information, information about lodging, and other relevant information on the Internet at http://www.fda.gov/UDI. Comments: Regardless of attendance at the public workshop, interested persons may submit either electronic or written comments by October 13, 2011. Submit electronic comments to http://www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. SUPPLEMENTARY INFORMATION: I. Background Section 226 of the Food and Drug Administration Amendments Act of 2007 (FDAAA) directs FDA to issue regulations establishing a UDI system for medical devices. FDA is developing proposed regulations to establish this UDI system to strengthen and improve FDA's enforcement of other statutory authorities and improve the identification of devices through distribution and use. This workshop will not address the FDA's UDI regulatory framework. However, UDI systems have been under development for some years by the U.S. and global device industry and some device manufacturers have been incorporating UDI into their product labeling and packaging. See http://www.fda.gov/UDI for more information about UDI. FDA is also leading an effort to develop and implement a national strategy for the best public health use of health-related electronic data related to devices that incorporates UDIs, including registries, and leverages existing processes and systems. Health-related data (from large data sources such as health insurers and integrated health systems, and others) contains a wealth of public health information that could be harnessed to contribute to understanding device safety and effectiveness. Currently, however, these data generally cannot be used to identify specific device exposures in patients. This is not the case for drug exposure, where the regular documentation of NDC numbers allows for robust analysis of pharmaceutical safety and effectiveness. Absent such information for devices, a vast amount of potentially useful data regarding patient safety and outcomes remains untapped. The incorporation of UDI into various health-related databases will greatly facilitate many important public health-related activities including: Reducing medical errors, Reporting and assessing device-related adverse events and product problems, Tracking of recalls, Assessing patient-centered outcomes and the risk/benefit profile of medical devices in large segments of the U.S. population, Providing an easily accessible source of device identification information to patients and health care professionals. The incorporation of UDI into various health-related databases would also greatly expand Sentinel Initiative capabilities to conduct active device surveillance given that Sentinel device data sources are currently limited to a few registries capturing short-term patient outcomes. FDA's Sentinel Initiative, on the Internet at http://www.fda.gov/Safety/FDAsSentinelInitiative/default.htm, seeks to establish ``a national electronic system that will transform FDA's ability to track the safety of drugs, biologics, medical devices--and ultimately all FDA-regulated products once they reach the market'' and ``aims to develop and implement a proactive system that will complement existing systems that the Agency has in place to track reports of adverse events linked to the use of its regulated products.'' (Please note that this workshop will NOT address FDA's oversight of EHRs.) II. Topics for Discussion at the Public Workshop This public workshop is intended to engage multiple stakeholders to inform FDA's efforts to promote and facilitate incorporation of UDIs into healthcare systems, obtain actionable information on the issues surrounding effective and efficient incorporation of UDIs into health- related electronic records, and understand best solutions and practices. To that end, we will focus on the following issues: A. Documenting Device Use Using UDIs in Electronic Health Records 1. The current state of documentation of device use in health- related databases, including EHRs. 2. The barriers to, and various possible incentives for, the development, implementation and use of UDI in EHR systems. 3. The possible roles and activities of various government stakeholders (including FDA, CMS, ONC, and NLM) necessary to drive the adoption and use of UDIs in EHRs and other health-related databases. 4. Any other issues or concerns that would

Read the complete text